Firm assessing Covid vaccine harm replaced after costs spiral to £48m
Summary
The NHS paid nearly £50 million to a company to assess claims of harm from Covid vaccines, which exceeded the original estimated cost of £6 million. The work, handled by Crawford & Company Adjusters, faced more claims than expected, leading to higher costs. A new company will take over this work soon.Key Facts
- Nearly £50 million was spent on assessing Covid vaccine harm claims.
- The original contract was estimated at £6 million.
- Over 22,000 claims were made, mostly related to the AstraZeneca vaccine.
- About 1% of the claims resulted in compensation payouts.
- A new company will replace Crawford & Company Adjusters in managing these claims.
- The Vaccine Damage Payment Scheme (VDPS) offers up to £120,000 for proven severe disabilities from vaccines.
- Compensation payouts to affected individuals totaled £29.8 million.
- Costs rose significantly due to the high volume of claims.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.